Evidence map›Paper›PMID 34016439›Full record

ArticleISA transactions2022

Controlling epidemic diseases based only on social distancing level: General case.

Samaherni Dias, Kurios Queiroz, Aldayr Araujo

Open access · greenAbstract read
In one paragraph

Article in ISA transactions, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Samaherni DiasLaboratory of Automation, Control, and Instrumentation (LACI), Department of Electrical Engineering, Federal University of Rio Grande do Norte (UFRN), Natal-RN, Brazil. Electronic address: sama@laci.ufrn.br.
Kurios QueirozLaboratory of Automation, Control, and Instrumentation (LACI), Department of Electrical Engineering, Federal University of Rio Grande do Norte (UFRN), Natal-RN, Brazil.
Aldayr AraujoLaboratory of Automation, Control, and Instrumentation (LACI), Department of Electrical Engineering, Federal University of Rio Grande do Norte (UFRN), Natal-RN, Brazil.
Universidade Federal do Rio Grande do Norte · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 outbreak is an epidemic disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). When a new virus emerges, generally, little is known about it, and no vaccines or other pharmaceutical interventions are available. In the case of a person-to-person transmission virus with no vaccines or other pharmaceutical interventions, the only way to control the virus outbreak is by keeping a sustained physical distancing between the individuals. However, to adjust the level of the physical distancing accurately can be so complicated. Any level above the necessary can compromise the economic activity, and any level below can collapse the health care system. This work proposes a controller to keep the number of hospitalized individuals below a limit, and a new group-structured model to describe the COVID-19 outbreak. The proposed controller is robust to the uncertainties in the parameters of the model and keeps the number of infected individuals controlled only by adjusting the social distancing level. Numerical simulations, to show the behavior of the proposed controller and model, are done.

Indexed as

COVID-19EpidemicsHumansPharmaceutical PreparationsPhysical DistancingSARS-CoV-2Pharmaceutical PreparationsControllerCOVID-19Epidemic diseaseSIR model

Identifiers

PMID34016439
PMCPMC8105642
OpenAlexW3163230506

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.